PILA PHARMA AB Financial Overview
PILA PHARMA AB's market cap is currently kr93.22M. The company's EPS TTM is kr-0.135; its P/E ratio is -5.74; PILA PHARMA AB is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
